You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The plaintiffs are concerned by the growth of DNA databases for law enforcement and want the government to automatically delete profiles of people not convicted of felonies.
Using genome sequence data for 429 accessions, an international team tracked chickpea's origin and spread, while identifying markers for important traits.
The researchers reported that most of these changes, though not all, reverted to normal upon the astronaut's return to Earth.
The Boston-based company offers a DNA test for dogs that it said can provide information on breed, ancestry, health, and disease risk.
The companies will use their respective technologies to optimize the cannabinoid profiles and other traits of different cannabis varieties.
The San Francisco-based startup, which closed a $5 million Series A round in 2017, aims to develop nutritionally enhanced food and feed crops.
The company — which is based in the US and trades on the Toronto Stock Exchange — announced plans for the private placement earlier this month.
The company plans to sell 7.9 million shares of common stock at $16 per share through its initial public offering.
Clear Labs will implement Oxford Nanopore's GridIon nanopore sequencing instrument with its Clear Safety platform to detect food-borne pathogens.
The firm claims that its Clear Safety platform will help food safety professionals detect food-borne pathogens and prevent outbreaks across the US.
The number of US states legalizing cannabis for medical and recreational use is growing, expanding the market for pathogen detection solutions.
The agriculture company said it will use the technology it has licensed for new applications in crop editing and for research to bring new foods to market.
The company — a spinout of the New York Genome Center — said it will use the funding in part to develop its technologies for new applications in agriculture.
The company said it intends to use the proceeds of the placement to continue work on its microfluidic PCR-based platform for pathogen detection.
The company also said it has been awarded a research sequencing grant from Illumina Accelerator.
The researchers analyzed samples from 60 countries to find antimicrobial resistance gene levels correlated with economic, health, and environmental factors.
The firms are focusing on developing a rapid diagnostic test for African swine fever that can be used on GNA's portable MDx platform.
Researchers assembled a near chromosome-level genome for the cultivated octoploid strawberry, uncovering the plant's diploid progenitors and sub-genome interactions.
Many variants that became more prevalent in different rabbit populations after viral exposure were associated with immune system functions, a new study suggests.
OmniVis is developing the assay for cholera detection in environmental samples while the lab that created it is working toward a paper-based HIV test.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.